logo
logo
Sign in

Fastest Growing Segment Fueling the Growth of Porcine Vaccines Market

avatar
Sneha
Fastest Growing Segment Fueling the Growth of Porcine Vaccines Market

The global Porcine Vaccines Market is estimated to be valued at US$ 2.4 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Porcine vaccines help prevent loss of livestock from various infectious diseases which supports sustainable livestock production. They induce immunity against bacterial and viral pathogens in animals through injectable or oral formulations.

Market key trends:

Precision livestock farming is gaining traction in the market. It uses automated systems like sensor technologies for managing farm operations and herd health in real-time. These sophisticated technologies identify issues and analyze massive data to gain insights into herd immunity levels, disease outbreak risk patterns and vaccination schedules. Porcine vaccines manufacturers are utilizing big data analytics to develop better formulations tailored to the needs of different farms. These technological advancements help improve disease management and promote efficient vaccine utilization.

Segment Analysis:

The global porcine vaccines market is segmented by technology, disease type, end-user, and region. Based on technology, the inactivated vaccines segment holds the largest market share due to its high efficacy and safety in treating various diseases such as PRRS, PED, and PCV2.

Key Takeaways:

The Global Porcine Vaccines Market Growth is expected to witness high, exhibiting CAGR of 5.2% over the forecast period, due to increasing prevalence of zoonotic diseases among pigs. The Asia Pacific is the fastest growing as well as dominating region due to rising pork consumption and growing animal healthcare expenditure in China and India. Key players operating in the porcine vaccines market are Boehringer Ingelheim International GmbH. (Germany), FORMOSA BIOMEDICAL INC. (Taiwan), Zoetis (U.S.), Dechra Pharmaceuticals PLC (U.K.), Hester Biosciences Limited. (India), Merck & Co., Inc. (U.S.), Novartis AG (Switzerland), Elanco (U.S.), Phibro Animal Health Corporation (U.S.), HIPRA, S.A (Spain), Bimeda, Inc (Ireland), Ceva (France), ARKO Laboratories (U.S.). The global porcine vaccines market size for 2023 is US$ 2.4 Bn.

The Asia Pacific dominates the porcine vaccines market owing to rising pork consumption in China and India. China is the largest producer and consumer of pork globally, hence driving high demand for porcine vaccines in the region.

Key players operating in the porcine vaccines market are focusing on new product launches. In 2023, Zoetis launched a new swine vaccine, Circumvent PCV M G2, to provide broader coverage against Porcine Circovirus Types 1 and 2 in nursery pigs. Merck also launched new Erysipelas and E. coli vaccines for pig farmers.


Read More - https://www.trendingwebwire.com/porcine-vaccines-market-share-and-demand-analysis/

collect
0
avatar
Sneha
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more